Teva Pharmaceutical Industries reported $40.04B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Aspen Pharmacare ZAR 108.27B 19.77B Jun/2026
Cipla INR 434.34B 9.38B Sep/2026
Dr.Reddys Laboratories INR 576.31B 1.01B Sep/2026
Guangzhou Baiy CNY 87.22B 603.21M Sep/2026
Jiangsu Hengrui CNY 76.72B 5.95B Sep/2026
Kalbe Farma IDR 33.4T 319.67B Sep/2026
Richter Gedeon HUF 1.69T 70.26B Jun/2026
Sh Fosun Pharma CNY 126.79B 1.36B Sep/2026
Sun Pharmaceuticals INR 1.15T 60.53B Sep/2026
Teva Pharmaceutical Industries USD 40.04B 185M Sep/2026